UW Madison Review of Covd-19 Research

Share

IEEE-Madison Engineers in Biology and Medicine Society Meeting


IEEE-Madison EMB18 Society Virtual Meeting via WebEx.

NOTE: Register with a proper email address -- a WebEx Invite will be sent prior to the meeting.

Video: The event is a video presentation of a recent update from Dr. Wiliam Hartman, medical director of the UW Health Preanesthesia Assessment Clinic and Professor and Dietram A. Scheufele, the Taylor-Bascom Chair in Science Communication and Vilas Distinguished Achievement Professor at the UW-Madison and in the Morgridge Institute for Research. Dr. Hartman covers research and clinical trials of Convalescent Plasma, Covid-19 Vaccine and Monoclonal Antibody studies at UW-Madison. Dr. Scheufele examines the formation of public attitudes and policy dynamics surrounding emerging science in the era if Covid-19.

Bio: William Hartman, MD/PhD is Assistant professor of Anesthesiology, School of Medicine and Public Health, and Medical Director of UW Health Pre-Op Clinic. He is the Principal Investigator for the UW COVID-19 Convalescent Plasma Program (Adult and Pediatric Programs) and the Principal Investogator for the UW-Regeneron Monoclonal Antibody (Antispike) Clinical Trials. He is also involved in the clinical trial of the Astra-Zenca covid-19 vaccine at UW.

Dietram A. Scheufele is the Taylor-Bascom Chair in Science Communication and Vilas Distinguished Achievement Professor at the University of Wisconsin-Madison and in the Morgridge Institute for Research. His research examines the formation of public attitudes and policy dynamics surrounding emerging science. He is an elected member of the German National Academy of Science and Engineering, a lifetime associate of the National Research Council, and a fellow of the American Association for the Advancement of Science, the International Communication Association, and the Wisconsin Academy of Sciences, Arts & Letters. His consulting experience includes work for DeepMind, Porter Novelli, PBS, WHO, and the World Bank.

==== WebEx Info for the meeting =====



Meeting number (access code): 126 896 7468
Meeting password: MPbgGSYP743 (67244797 from phones and video systems)

Wednesday, November 18, 2020
7:00 pm | (UTC-06:00) Central Time (US & Canada) | 1 hr 30 mins

Join meeting link here.

Tap to join from a mobile device (attendees only)
+1-415-655-0001,,1268967468#67244797# US Toll
Some mobile devices may ask attendees to enter a numeric meeting password.

Join by phone
+1-415-655-0001 US Toll
Global call-in numbers

Join by video system, application or Skype for business
Dial 1268967468@webex.com
You can also dial 173.243.2.68 and enter your meeting number.

==================================



  Date and Time

  Location

  Hosts

  Registration



  • Date: 18 Nov 2020
  • Time: 07:00 PM to 08:15 PM
  • All times are US/Central
  • Add_To_Calendar_icon Add Event to Calendar
If you are not a robot, please complete the ReCAPTCHA to display virtual attendance info.
  • Madison, Wisconsin
  • United States

  • Co-sponsored by IEEE-Madison Section
  • Starts 10 November 2020 02:11 PM
  • Ends 18 November 2020 10:11 AM
  • All times are US/Central
  • No Admission Charge


  Speakers

Dr. Hartman of University of Wisconsin

Topic:

Medical Research on Covid-19

Dr. Hartman will discuss the use of Convalescent Plasma, Monoclonal Antibodies, and vaccines to treat/prevent covid-19.

Biography:

Dr. Hartman,  Assistant professor of Anesthesiology, School of Medicine and Public Health, and Medical Director of UW Health Pre-Op Clinic. He is the Principal Investigator for the UW COVID-19 Convalescent Plasma Program (Adult and Pediatric Programs) and the Principal Investogator for the UW-Regeneron Monoclonal Antibody (Antispike) Clinical Trials. He is also involved in the clinical trial of the Astra-Zenca covid-19 vaccine at UW.

Dr. Scheufele of University of Wisconsin

Topic:

Communicating Advanced Scientific Results for Covid-19

This research examines the formation of public attitudes and policy dynamics surrounding emerging science for Covid-19. 

Biography:

Dietram A. Scheufele is the Taylor-Bascom Chair in Science Communication and Vilas Distinguished Achievement Professor at the University of Wisconsin-Madison and in the Morgridge Institute for Research. He is an elected member of the German National Academy of Science and Engineering, a lifetime associate of the National Research Council, and a fellow of the American Association for the Advancement of Science, the International Communication Association, and the Wisconsin Academy of Sciences, Arts & Letters. His consulting experience includes work for DeepMind, Porter Novelli, PBS, WHO, and the World Bank.

Scheufele has won the Cornell University College of Agriculture and Life Sciences Young Faculty Teaching Award and the University of Wisconsin–Madison College of Agricultural and Life Sciences Spitzer Excellence in Teaching Award.

Over the course of his career, he has held fellowships or visiting appointments at a number of other universities, including Harvard, Penn, the Technische Universität Dresden, the Ludwig-Maximilians-Universität München, the Westfälische Wilhelms-Universität Münster, and – most recently – the Universität Wien.

Scheufele currently co-chairs the National Academy of Sciences, Engineering, and Medicine’s Standing Committee on Advancing Science Communication, and serves on NASEM’s Division of Behavioral and Social Sciences and Education (DBASSE) Advisory Committee, the Board on Health Sciences Policy, and the Division on Earth and Life Studies (DELS) Advisory Committee. Since 2012, he has co-organized four NASEM Colloquia on the Science of Science Communication.





Agenda

7:00 to 8:05 PM Talk via WebEx (Register with email address to get an invite)

8:05 PM Questions